Studies have also indicated that restoring or overexpressing PIAS3, via repression of STAT3‐mediated oncogenic pathways, shows inhibitory effects on cancer cells (Borghouts et al., 2010; Brantley et al., 2008; Dabir et al., 2014; Saydmohammed et al., 2010). The gene discussed is STAT3; the disease is cancer.